Progress in the study of response surface modeling in investigation of drug-drug interaction in anesthetic drugs

Yaoxue Xuebao

Volumn 43, Issue 12, 2008, Pages 1171-1178

  Guan, Zheng ^a   Bi, Shan Shan ^a   Yang, Lu ^a   Zhang, Li Ping ^a   Zhou, Tian Yan ^a   Lu, Wei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Anesthetic drug; Drug drug interaction; Response surface model

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; MIDAZOLAM; PROPOFOL;

COMPUTER SIMULATION; DRUG INTERACTION; DRUG POTENTIATION; HUMAN; REVIEW; STATISTICAL MODEL;

ALFENTANIL; ANESTHETICS; COMPUTER SIMULATION; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; MIDAZOLAM; MODELS, STATISTICAL; PROPOFOL;

EID: 57749197406     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Box GEP, Wilson KB. On the experimental attainment of optimum conditions (with discussion) [J]. J R Stat Soc B, 1951,13:1-45.
2. Prichard MN, Shipman C Jr. A three-dimensional model to analyze drug-drug interactions [J]. Antiviral Res, 1990,14:181-205.
3. Fraser TR. The antagonism between the actions of active substances [J]. Br Med J, 1872,2:485-487.
4. Bauer DJ. The antiviral and synergistic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice [J]. Br J Exp Pathol, 1954, 36:105-114.
5. Berenbaum MC. What is synergy? [J]. Pharmacol Rev, 1989,41:93-141.
6. Kern SE, Xie G, White JL, et al. A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers [J]. Anesthesiology, 2004, 100:1373-1381.
7. Tallarida RJ, Porreca F, Crowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms [J]. Life Sci, 1989,45:947-961.
8. Tallarida RJ. Statistical analysis of drug combination of synergism [J]. Pain, 1992,49:93-97.
9. Tallarida RJ. Drug synergism: its detection and application [J]. J Pharmacol Exp Ther, 2001,298; 865-872.
10. Meletiadis J, Mouton JW, Meis JF, et al. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates [J]. Antimicrob Agents Chemother, 2003,47; 106-117.
11. Joseph M, Debbie TA, te Dorsthorst PE. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions [J]. Int J Antimicrob Agents, 2006,28:439-449.
12. te Dorsthorst, Debbie TA, Verweij PE, et al. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models [J]. Antimicrob Agents Chemother, 2004,48:2007-2013.
13. Luszczki JJ, Czuczwar SJ. Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics-a comparative study [J]. Epilepsy Res, 2003,56:27-42.
14. Satyanarayana PS, Jain NK, Singh A, et al. Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2004,28:641-649.
15. Miranda HF, Pinardi G. Isobolographic analysis of the antinociceptive interactions of clonidine with nonsteroidal anti-inflammatory drugs [J]. Pharmacol Res, 2004,50: 273-278.
16. Daniel M, Jonker, Sandra AG, et al. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo [J]. Pharmacol Ther, 2005,106:1-18.
17. Kong M, Lee JJ. A generalized response surface model with varying relative potency for assessing drug interaction [J]. Biometrics, 2006,62:986-995.
18. White DB, Faessel HM, Slocum HK et al. Nonlinear response surface and mixture experiment methodologies applied to the study of synergy [J]. Biometrical J, 2004, 46:56-71.
19. Grabovsky Y, Tallarida RJ. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles [J]. J Pharmacol Exp Ther, 2004,310:981-986.
20. Kissin I. General anesthetic action; an obsolete notion? [J]. Anesth Analg 1993,76:215-218.
21. Short TG, Plummer JL, Chui PT. Hypnotic and anesthetic interactions between midazolam, propofol and alfentanil [J]. Br J Anaesth, 1991,67:539-545.
22. Vuyk J, Lim T, Engbers FH, et al. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgerying women [J]. Anesthesiology, 1995,83:8-22.
23. Vuyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection; determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness [J]. Anesthesiology, 1997,87:1549-1562.
24. Glass PS, Can TJ, Howell S, et al. Drug interactions: volatile anesthetics and opioids [J]. J Clin Anesth, 1997,9:185-228.
25. Minto C, Vuyk J. Response surface modeling of drug interactions [J]. Adv Exp Med Biol, 2003,523:35-43.
26. Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective [J]. Pharmacol Rev, 1995,47:331-385.
27. Minto CF, Schnider TW, Short TG, et al. Response surface model for anesthetic drug interactions [J]. Anesthesiology, 2000,92:1603-1616.
28. Beal SL, Sheiner LB. Nonmem User's Guide [Z]. San Francisco, University of California, 1998.
29. Short TG, Ho TY, Minto CF, et al. Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic model-based response surface describing the interaction between two intravenous anesthetic drugs [J]. Anesthesiology, 2002,96:400-408.
30. Bührer M, Maitre PO, Hung O, et al. Electroence-phalographic effects of benzodiazepines. I. Choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system [J]. Clin Pharmacol Ther, 1990,48:544-554.
31. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age; a simultaneous pharmacokinetic and pharmacodynamic evaluation [J]. J Pharmacol Exp Ther, 1987,240:159-166.
32. van Kleef WJ, Dahan A, Teppema JL. Cardio Respiratory Control in the Perioperative Patient [M]. Wageningen; Pensen Looijen BV, 2002.
33. Yang L, Yang BX, Zhang LP, et al. Pharmaeokinetic/ pharmacodynamic studies in anesthetic drug-drug interactions-a response surface model with remifentanil and sevoflurane for Chinese adult patients [J]. Chin J Pharmacol Ther, 2007,10:1151-1156.
34. Manyam SC, Gupata DK. Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes [J]. Anesthesiology, 2006, 105:267-278.
35. Bol CJ, Vogelaar JP, Tang JP, et al. Quantification of pharmacodynamic interactions between deunedetomidine and midazolam in the rat [J]. J Pharmacol Exp Ther, 2000,294:347-355.
36. Zanderigo E, Sartori V, Sveticic G. A new model for drug interactions and optimal drug dosing [C]. 27th Annual International Conference of the 2005, 2353-2356.
37. Zanderigo E, Sartori V, Sveticic G. The well-being model; a new drug interaction model for positive and negative effects [J]. Anesthesiology, 2006,104:742-753.
38. Mertens MJ, Olofsen E. Propofol reduces perioperative remifentanil requirements in a synergistic manner [J]. Anesthesiology, 2003,99:347-359.
39. Caruso A, Schumacher PM, Morari M. A novel direct search method for the optimization of multiple-drug regimens for pain treatment [C]. Anesthesiology, Proceedings of the ASA Annual Meeting, 2008.
40. Caruso A, Bouillon T, Schumacher PM. Control of drug administration during monitored anesthesia care [C]. IEEE Transactions on Automation Science and Engineering, Special Issue on Drug Delivery 2008.
41. Barbosa MDM. A methodology for finding optimal dosage levels in multi-drug treatment interactions [J]. Comput Methods Programs Biomed, 1994,43:239.
42. Bouillon TW, Bruhn J, Radulescu L, et al. Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, Bispectral Index, and electroencephalographic approximate entropy [J]. Anesthesiology, 2004,100:1353-1572.
43. Glass PS. Anesthetic drug interactions; an insight into general anesthesia; Its mechanism and dosing strategies [J]. Anesthesiology, 1998,88:5-6.
44. Ausems ME, Hug CC Jr, Stanski DR, et al. Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery [J]. Anesthesiology, 1986,65:362-373.
45. Dahan A, Nieuwenhuijs D, Olofsen E, et al. Response surface modeling of alfentanil-sevoflurane interaction on cardiorespiratory control and Bispectral Index [J]. Anesthesiology, 2001,94:982-991.
46. Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil [J]. Br J Anaesth, 1992,69:162-167.